等待開盤 07-18 09:30:00 美东时间
+0.001
+0.08%
TOMI Environmental Solutions successfully installed its first SteraMist Integration System - Standalone (SIS-SA) in the pharmaceutical isolator market, targeting the growing life sciences sterility testing sector. The installation, part of the company's strategy to expand in the life sciences industry, reflects increasing demand for sterile drug manufacturing. The SIS-SA, featuring a 90-degree applicator, was retrofitted into an existing isolator...
07-16 12:30
2025年6月19日,浙江同富特美刻家居用品股份有限公司(简称:同富股份)拟在上交所主板上市的消息引发了资本市场的广泛关注。此次其计划募资总金额为8.2亿元,保...
07-03 17:37
TOMI Environmental Solutions, Inc.® ("TOMI") (NASDAQ:TOMZ), a global company specializing in disinfection and decontamination solutions, today announced significant advancements in the fight against the devastating
06-23 21:57
USDA collaborates with TOMI to use SteraMist to combat DWV, key cause of bee colony loss. This advancement highlights protect bees through non-toxic solution, crucial for agriculture.
06-23 13:52
TOMI Environmental Solutions (NASDAQ:TOMZ) announced on Thursday the appointment of David Vanston as chief financial officer (CFO), effective May 30, 2025. Vanston held senior finance roles at both pr...
06-05 21:50
TOMI Environmental Solutions, Inc. announced the appointment of Mr. David Vanston as its Chief Financial Officer. With over 25 years of experience in finance across life sciences, manufacturing, and technology sectors, Vanston holds an MBA and is a Fellow of the Chartered Certified Accountants. His leadership will support TOMI's growth strategy. The company also thanked Nick Jennings for his service during the transition. TOMI specializes in disi...
06-05 12:30
Gainers Rain Enhancement (NASDAQ:RAIN) shares increased by 7.9% to $3.4 during...
06-03 05:05
TOMI Environmental Solns (NASDAQ:TOMZ) reported quarterly losses of $(0.01) per share. This is a 85.71 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly
05-09 04:19
Companies Reporting Before The Bell • Sempra (NYSE:SRE) is likely to report qua...
05-08 16:33
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1119185980869894144.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Canaccord Genuity:维持Verve Therapeutics(VERV)"买入"评级,目标价从32美元升至39美元</p> <p>• HC Wainwright & Co.:维持Verve Ther
04-16 09:45